Insider Transactions in Q2 2025 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2025
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,000
-1.33%
|
$1,060,000
$53.51 P/Share
|
|
Jun 24
2025
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.58%
|
$160,000
$8.11 P/Share
|
|
Jun 23
2025
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,000
-2.65%
|
$1,040,000
$52.57 P/Share
|
|
Jun 23
2025
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.58%
|
$160,000
$8.11 P/Share
|
|
Jun 20
2025
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,000
-2.65%
|
$1,040,000
$52.96 P/Share
|
|
Jun 20
2025
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.58%
|
$160,000
$8.11 P/Share
|
|
Jun 12
2025
|
Mark Howard Snyder SVP, CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,711
-8.09%
|
$146,394
$54.54 P/Share
|
|
Jun 12
2025
|
Mark Howard Snyder SVP, CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,035
+13.06%
|
-
|
|
May 01
2025
|
Matthew L. Posard |
BUY
Grant, award, or other acquisition
|
Direct |
4,165
+5.33%
|
-
|
|
May 01
2025
|
Barbara Gayle Duncan |
BUY
Grant, award, or other acquisition
|
Direct |
4,165
+17.29%
|
-
|
|
May 01
2025
|
Jeffrey William Henderson |
BUY
Grant, award, or other acquisition
|
Direct |
4,165
+11.27%
|
-
|
|
May 01
2025
|
Mahesh Krishnan |
BUY
Grant, award, or other acquisition
|
Direct |
4,165
+28.08%
|
-
|
|
May 01
2025
|
Akiko Moni Miyashita |
BUY
Grant, award, or other acquisition
|
Direct |
4,165
+14.31%
|
-
|
|
May 01
2025
|
Bernadette Connaughton |
BUY
Grant, award, or other acquisition
|
Direct |
4,165
+7.56%
|
-
|
|
Apr 28
2025
|
Jeffrey William Henderson |
SELL
Open market or private sale
|
Direct |
4,497
-6.84%
|
$269,820
$60.67 P/Share
|
|
Apr 01
2025
|
Jeffrey William Henderson |
SELL
Open market or private sale
|
Direct |
503
-1.5%
|
$32,192
$64.05 P/Share
|